Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 8 | |
Outperform | 7 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 14 analysts offering 12 month price targets for Revolution Medicines Inc have a median target of 70.00, with a high estimate of 86.00 and a low estimate of 63.00. The median estimate represents a 15.82% increase from the last price of 60.44.
High | 42.3% | 86.00 |
Med | 15.8% | 70.00 |
Low | 4.2% | 63.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 24, 2025.
Average growth rate | -1.99% |
Average growth rate | +4.49% |
More ▼
Revenue history & estimates in USD
Average growth rate | -33.33% |
Average growth rate | -23.15% |
More ▼